HOUSE DOCKET, NO. 2220        FILED ON: 1/15/2025

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No.         

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

John Francis Moran and Samantha Montaño

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act to clarify prescription monitoring program activities.

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

John Francis Moran

9th Suffolk

1/15/2025

Samantha Montaño

15th Suffolk

1/17/2025

Carmine Lawrence Gentile

13th Middlesex

1/21/2025

Mindy Domb

3rd Hampshire

2/5/2025


HOUSE DOCKET, NO. 2220        FILED ON: 1/15/2025

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No.         

[Pin Slip]

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Fourth General Court
(2025-2026)

_______________

 

An Act to clarify prescription monitoring program activities.

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Section 24A of chapter 94C of the General Laws, as appearing in the 2022 Official Edition, is hereby amended by inserting after subsection (m) the following subsection:-

(n) Notwithstanding subsection (a)(1), the department shall exclude testosterone from the list of drugs monitored in the prescription drug monitoring system. 

SECTION 2. Immediately upon passage of this Act, the department shall delete from the prescription monitoring system established under said section 24A any existing data concerning the prescribing and dispensing of testosterone.